BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32730594)

  • 1. Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.
    Yoshino S; Yokoyama T; Sunami Y; Takahara T; Nakamura A; Yamazaki Y; Tsutsumi S; Aburatani H; Nakamura T
    Blood; 2021 Jan; 137(1):75-88. PubMed ID: 32730594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trib1 links the MEK1/ERK pathway in myeloid leukemogenesis.
    Yokoyama T; Kanno Y; Yamazaki Y; Takahara T; Miyata S; Nakamura T
    Blood; 2010 Oct; 116(15):2768-75. PubMed ID: 20610816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Trib1 in myeloid leukaemogenesis and differentiation.
    Nakamura T
    Biochem Soc Trans; 2015 Oct; 43(5):1104-7. PubMed ID: 26517931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1.
    Yoshida A; Kato JY; Nakamae I; Yoneda-Kato N
    Blood; 2013 Sep; 122(10):1750-60. PubMed ID: 23884858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.
    Keeshan K; Vieugué P; Chaudhury S; Rishi L; Gaillard C; Liang L; Garcia E; Nakamura T; Omidvar N; Kogan SC
    Haematologica; 2016 Oct; 101(10):1228-1236. PubMed ID: 27390356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia.
    Dedhia PH; Keeshan K; Uljon S; Xu L; Vega ME; Shestova O; Zaks-Zilberman M; Romany C; Blacklow SC; Pear WS
    Blood; 2010 Aug; 116(8):1321-8. PubMed ID: 20410507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBX3 is an important cofactor of HOXA9 in leukemogenesis.
    Li Z; Zhang Z; Li Y; Arnovitz S; Chen P; Huang H; Jiang X; Hong GM; Kunjamma RB; Ren H; He C; Wang CZ; Elkahloun AG; Valk PJ; Döhner K; Neilly MB; Bullinger L; Delwel R; Löwenberg B; Liu PP; Morgan R; Rowley JD; Yuan CS; Chen J
    Blood; 2013 Feb; 121(8):1422-31. PubMed ID: 23264595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
    Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia.
    Nakamae I; Kato JY; Yokoyama T; Ito H; Yoneda-Kato N
    Blood Adv; 2017 Sep; 1(20):1682-1693. PubMed ID: 29296815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.
    Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L
    J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis.
    Salomé M; Hopcroft L; Keeshan K
    Exp Hematol; 2018 Oct; 66():63-78.e13. PubMed ID: 30031847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
    Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
    Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia.
    Zha J; Lai Q; Deng M; Shi P; Zhao H; Chen Q; Wu H; Xu B
    Stem Cell Rev Rep; 2020 Dec; 16(6):1280-1291. PubMed ID: 33057942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.
    Jin G; Yamazaki Y; Takuwa M; Takahara T; Kaneko K; Kuwata T; Miyata S; Nakamura T
    Blood; 2007 May; 109(9):3998-4005. PubMed ID: 17227832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
    Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tribbles homolog 2 (Trib2) and HoxA9 cooperate to accelerate acute myelogenous leukemia.
    Keeshan K; Shestova O; Ussin L; Pear WS
    Blood Cells Mol Dis; 2008; 40(1):119-21. PubMed ID: 17988908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of TRIB1 R107L gain-of-function mutation in human acute megakaryocytic leukemia.
    Yokoyama T; Toki T; Aoki Y; Kanezaki R; Park MJ; Kanno Y; Takahara T; Yamazaki Y; Ito E; Hayashi Y; Nakamura T
    Blood; 2012 Mar; 119(11):2608-11. PubMed ID: 22294728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
    Rishi L; Hannon M; Salomè M; Hasemann M; Frank AK; Campos J; Timoney J; O'Connor C; Cahill MR; Porse B; Keeshan K
    Blood; 2014 Apr; 123(15):2389-400. PubMed ID: 24516045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome.
    Yoshino S; Tanaka M; Sunami Y; Takahara T; Yamazaki Y; Homme M; Niibori-Nambu A; Osato M; Minami T; Ishihara K; Nakamura T
    Leukemia; 2022 Feb; 36(2):558-561. PubMed ID: 34381180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.